Aehr Test Systems (AEHR) Scores Historic $41M AI Chip Contract, Stock Jumps 15%

TLDR

• AEHR shares climbed 15.41% Thursday following disclosure of a landmark $41 million production contract from a hyperscale client.
• The contract involves package-level burn-in testing for custom AI processor ASICs utilizing Aehr’s Sonoma high-power platform.
• Shipments are scheduled to commence in fiscal 2027, beginning June 27, 2026.
• One company director liquidated $1.21 million worth of shares on April 16, one day prior to the public announcement.
• Analyst consensus stands at Strong Buy with a mean price target of $62.

Aehr Test Systems secured its largest contract ever on Thursday, sending shares sharply higher. The semiconductor testing specialist revealed a $41 million production agreement with its primary hyperscale client for package-level burn-in testing of custom AI processor ASICs. AEHR stock jumped 15.41% following the disclosure.

Aehr Test Systems, AEHR

The agreement encompasses a significant quantity of Aehr’s Sonoma high-power package-level testing and burn-in platforms. Additionally, the contract includes turnkey burn-in modules along with device-specific sockets designed to configure the systems for particular AI processors.

This represents a repeat purchase, indicating the hyperscale customer — whose name remains undisclosed — has previously engaged with Aehr. The arrangement strengthens an already expanding partnership.

Shipments are scheduled to commence in Aehr’s fiscal 2027, which begins on June 27, 2026. This provides the company with a well-defined revenue pipeline in the near term.

CEO Gayn Erickson emphasized that this contract represents just the beginning. He pointed out that the customer is simultaneously developing a next-generation, higher-power AI accelerator ASIC anticipated to enter production later this year.

Aehr has already secured an initial purchase order from this identical customer for several Sonoma systems to facilitate production of the advanced device. This suggests the $41 million contract may be merely the opening chapter of a much larger opportunity.

Impressive Performance Leading Up to the News

Thursday’s rally builds upon what has been an extraordinary period for AEHR. The stock has surged 246.95% year-to-date and has rocketed 805.07% over the trailing twelve months.

More than 1.75 million AEHR shares traded hands during the session, approaching the three-month average daily trading volume of approximately 2.77 million.

The historic contract also follows solid Q3 2026 financial results. Revenue reached $10.3 million, marginally below the $10.8 million estimate, though the company reported record quarterly bookings totaling $37.2 million. This achievement elevated its backlog beyond $50 million.

Regarding earnings per share, Aehr exceeded projections — delivering -$0.05 versus the anticipated -$0.07.

Wall Street and Insider Transactions

Analysts have been upgrading their price objectives. Freedom Broker increased its price target to $61 from $38 while maintaining a Hold rating. Lake Street elevated its target to $56 from $50, highlighting robust booking trends, and retained its Buy rating.

The prevailing Wall Street consensus stands at Strong Buy, with three Buy recommendations issued in the past three months. The mean price target reaches $62, suggesting approximately 26.67% upside potential from current levels.

Regarding insider transactions, Director Rhea J. Posedel divested 15,000 shares on April 16 at $80.72 per share, generating proceeds of $1.21 million. After this transaction, Posedel maintains direct ownership of 71,163 shares, along with an additional 411,979 shares held indirectly via a trust.

The post Aehr Test Systems (AEHR) Scores Historic $41M AI Chip Contract, Stock Jumps 15% appeared first on Blockonomi.